Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Metoprolol Succinate in Adults With Symptomatic oHCM
Clinical trial NCT05767346 · COMPLETED
Trial details
- NCT number
- NCT05767346
- Sponsor
- Cytokinetics
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-20
- Primary completion
- 2025-02-28
- Enrollment
- 175
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.